As the Director of Access and Innovation at Roche Diagnostics, Chris Hudson leverages over thirty-five years of extensive experience in General Management, Business Development, and Marketing across diverse sectors including OTC, Prescription Medicines, Medical Diagnostics, and Medical Devices. In this pivotal role, Chris is at...
As the Director of Access and Innovation at Roche Diagnostics, Chris Hudson leverages over thirty-five years of extensive experience in General Management, Business Development, and Marketing across diverse sectors including OTC, Prescription Medicines, Medical Diagnostics, and Medical Devices. In this pivotal role, Chris is at the forefront of pioneering initiatives that enhance access to innovative healthcare solutions, ultimately aiming to improve patient outcomes and the overall health of populations.
Under his leadership, the Access and Innovation Directorate is dedicated to fostering collaborations with healthcare partners to create tangible value for patients. Chris is instrumental in driving strategic projects that focus on the adoption of cutting-edge diagnostics and therapeutic innovations, ensuring that these advancements are not only accessible but also effectively integrated into healthcare systems. His expertise in project management and strategy development enables him to navigate complex regulatory landscapes and advocate for policies that facilitate the introduction of transformative healthcare solutions.
Chris’s commitment to improving healthcare access is complemented by his strong skills in direct lobbying and international sales operations, particularly in the realm of Diabetes Care and Clinical Nutrition. His ability to motivate and lead cross-functional teams ensures that Roche Diagnostics remains at the forefront of healthcare innovation. By aligning the company’s objectives with the needs of patients and healthcare providers, Chris Hudson is making significant strides in reshaping the future of healthcare delivery.
